Toxoid Vaccine Market to reach US$ 7.67 billion by 2032, growing at a CAGR of 3.86%
The Toxoid Vaccine Market has been experiencing significant growth, driven by various global health initiatives, technological advancements, and increasing awareness about the importance of immunization in preventing infectious diseases. According to WHO, immunization prevents 2-3 million deaths every year from vaccine-preventable diseases, and the impact of toxoid vaccines in reducing these numbers is substantial.